IoT in the EU: Lessons from COVID-19, and next steps for liability and regulation

Connected products remain in focus during 2020. Now more than ever before, they bring new opportunities to our homes, work, travel, and health care.

The impact of the "Schrems II" case on privacy shield and data transfers

The "Schrems II" case changed the privacy landscape by invalidating the EU-U.S. Privacy Shield Framework and upholding the use of standard contractual clauses. In this meeting, experienced...

The Schrems II Decision: The Day After

We hope you can join us for this timely webinar brought to you by IAPP featuring Eduardo Ustaran, Global co-head of the Hogan Lovells Privacy and Cybersecurity practice.

Virtual health: What's on the horizon for telehealth and remote monitoring?

As the world responds to the COVID-19 pandemic, physicians and patients are increasingly turning to virtual health solutions, including telehealth and remote monitoring, as a central facet...

Internet of Things or Internet of Payments?

Making (the Internet of) Things pay? Will cars, fridges, watches, printers, and other moving and non-moving parts of the Internet of Things know value for money when they see it?

AI and Drug Development: IP and data protection challenges

Artificial intelligence (AI) is not new to the life sciences industry but its use in drug development is rapidly growing, as life sciences companies increasingly recognize the benefits of...

Silicon Valley: Life Sciences and Health Care Horizons 2019

Join us in Silicon Valley: Local insights for global reach

Tech - Exposed in a downturn

Tech has been transformed in the last decade. Does value invested in the cloud, big data and algorithms create new risks and opportunities if there is an economic downturn. If so, what...

Loading data